rs766440921
Variant summary
Our verdict is Uncertain significance. Variant got 3 ACMG points: 3P and 0B. PM2PP3
The NM_138773.4(SLC25A46):c.385G>A(p.Val129Ile) variant causes a missense, splice region change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000255 in 1,570,626 control chromosomes in the GnomAD database, with no homozygous occurrence. 2/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_138773.4 missense, splice_region
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 3 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SLC25A46 | NM_138773.4 | c.385G>A | p.Val129Ile | missense_variant, splice_region_variant | Exon 4 of 8 | ENST00000355943.8 | NP_620128.1 | |
SLC25A46 | NM_001303249.3 | c.385G>A | p.Val129Ile | missense_variant, splice_region_variant | Exon 4 of 8 | NP_001290178.1 | ||
SLC25A46 | NM_001303250.3 | c.112G>A | p.Val38Ile | missense_variant, splice_region_variant | Exon 4 of 8 | NP_001290179.1 | ||
SLC25A46 | NR_138151.2 | n.498G>A | splice_region_variant, non_coding_transcript_exon_variant | Exon 4 of 9 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000132 AC: 2AN: 151938Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.00000460 AC: 1AN: 217452Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 118574
GnomAD4 exome AF: 0.00000141 AC: 2AN: 1418688Hom.: 0 Cov.: 27 AF XY: 0.00000142 AC XY: 1AN XY: 706552
GnomAD4 genome AF: 0.0000132 AC: 2AN: 151938Hom.: 0 Cov.: 32 AF XY: 0.0000270 AC XY: 2AN XY: 74202
ClinVar
Submissions by phenotype
Neuropathy, hereditary motor and sensory, type 6B Uncertain:1
In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be disruptive, but these predictions have not been confirmed by published functional studies and their clinical significance is uncertain. This variant has not been reported in the literature in individuals with SLC25A46-related disease. This variant is present in population databases (rs766440921, ExAC 0.006%). This sequence change replaces valine with isoleucine at codon 129 of the SLC25A46 protein (p.Val129Ile). The valine residue is highly conserved and there is a small physicochemical difference between valine and isoleucine. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at